In patients with uveal melanoma, researchers evaluated quality of life (QoL) status through the National Comprehensive Cancer Network (NCCN) distress thermometer as a psycho-oncological screening tool.
Archive | Melanoma News
The National Comprehensive Cancer Network distress thermometer as a screening tool for the evaluation of quality of life in uveal melanoma patients
Posted in Melanoma News, Publications, Scientific Publications
Lentigo Maligna Clinical Practice Guidelines (2019)
The diagnosis of lentigo maligna is made using the results from biopsy and histopathology studies. Because the risk of lentigo maligna progressing to invasive melanoma generally is low and can take many years, watchful waiting (monitoring the lesions over time) may be a more appropriate approach in very elderly patients or those with significant comorbidities.
Posted in Melanoma News, Health Professionals, Of Interest
Dr. Sznol Discusses the Combination of Ipilimumab and Nivolumab in Melanoma
Mario Sznol, MD, professor of medicine, co-director, Yale SPORE in Skin Cancer, Yale Cancer Center, discusses the benefits of immunotherapy, specifically the combination of the CTLA-4 inhibitoripilimumab (Yervoy) and the PD-1 inhibitor nivolumab (Opdivo), in melanoma.
Posted in Melanoma News, Health Professionals, Video Reports
Response to Initial Immunotherapy Treatment Predicts Melanoma Outcomes
I’m Dr Jeffrey Weber, deputy director of the Laura and Isaac Perlmutter Cancer Center at NYU Langone Health in New York City.
Posted in Melanoma News, Health Professionals, Of Interest
